| Upcoming events on ABBOTT LABORATORIES |
|
| 10/14/20 | | Q3 2020 Earnings Release (Projected) |
| 01/27/21 | | FY 2020 Earnings Release (Projected) |
| 04/21/21 | | Q1 2021 Earnings Release (Projected) |
| 07/21/21 | | Interim 2021 Earnings Release (Projected) |
|
| Past events on ABBOTT LABORATORIES |
|
| 07/16/20 | 09:30am | | Interim 2020 Earnings Call |
| 07/16/20 | 07:30am | | Interim 2020 Earnings Release |
| 07/14/20 | | Ex-dividend day for |
| 06/25/20 | | European Association of Percutaneous Cardiovascular Interventions Conference |
|
| Upcoming sector events for ABBOTT LABORATORIES |
|
- No events available - | |
|
| Past sector events for ABBOTT LABORATORIES |
|
- No events available -
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M $ |
Released
Forecast
Spread | 20 405
20 468
-0,31% | 20 853
20 894
-0,20% | 27 390
27 194
0,72% | 30 578
30 652
-0,24% | 31 904
31 846
0,18% |
33 067
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 4 850
4 918
-1,4% | 5 525
4 976
11% | 7 022
6 968
0,78% | 9 833
7 757
27% | 8 188
8 266
-0,94% |
8 327
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 3 979
4 024
-1,1% | 4 172
4 167
0,13% | 5 976
6 010
-0,56% | 6 555
6 616
-0,91% | 7 110
7 149
-0,55% |
7 284
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 3 183
3 558
-11% | 1 413
3 065
-54% | 2 231
3 867
-42% | 2 873
2 782
3,3% | 4 077
3 920
4,0% |
4 052
|
Net income
M $ |
Released
Forecast
Spread | 2 606
2 427
7,4% | 1 063
2 105
-50% | 353
1 805
-80% | 2 334
2 380
-1,9% | 3 687
3 655
0,87% |
3 667
|
EPS
$ |
Released
Forecast
Spread | 1,72
1,68
2,6% | 0,71
1,79
-60% | 0,20
1,00
-80% | 1,31
1,34
-2,5% | 2,06
2,10
-1,7% |
2,07
| | Announcement Date | 01/28/2016 | 01/25/2017 | 01/24/2018 | 01/23/2019 | 01/22/2020 | |
|
|
|
| Quarterly results | 2018 Q1 | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 (e) | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) |
Sales
M $ |
Released
Forecast
Spread | 7 390
7 283
1,5% | 7 767
7 707
0,77% | 7 656
7 651
0,07% | 7 765
7 824
-0,76% | 7 535
7 491
0,59% | 7 979
7 997
-0,22% | 8 076
8 104
-0,35% | 8 314
8 256
0,70% | 7 726
7 472
3,4% | 7 328
6 853
6,9% |
8 471
|
9 449
|
8 778
|
8 907
|
9 250
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 1 656
1 689
-2,0% | 1 950
1 913
1,9% | 1 996
2 006
-0,51% | 2 541
2 158
18% | 1 693
1 690
0,18% | 2 054
2 076
-1,1% | 2 133
2 150
-0,79% | 2 308
2 385
-3,2% | 1 697
1 541
10% | 1 587
1 107
43% |
2 277
|
2 882
|
2 422
|
2 588
|
2 822
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 1 388
1 366
1,6% | 1 662
1 630
1,9% | 1 727
1 704
1,4% | 1 778
1 838
-3,3% | 1 426
1 397
2,1% | 1 786
1 788
-0,09% | 1 863
1 859
0,20% | 2 035
2 075
-1,9% | 1 430
1 339
6,8% | 1 315
943
39% |
1 976
|
2 570
|
1 985
|
2 170
|
2 329
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 409
344
19% | 718
706
1,7% | 552
603
-8,4% | 655
703
-6,8% | 672
512
31% | 1 006
841
20% | 960
976
-1,6% | 1 049
1 109
-5,4% | 564
449
26% | 537
169
217% |
1 070
|
1 511
|
997
|
1 087
|
1 240
|
Net income
$ |
Released
Forecast
Spread | 0,23
0,20
18% | 0,40
0,40
0,00% | 0,31
0,37
-16% | 0,37
0,42
-12% | 0,38
0,30
28% | 0,56
0,48
16% | 0,53
0,56
-5,3% | 0,59
0,64
-7,5% | 0,31
0,25
23% | 0,30
0,12
147% |
0,60
|
0,86
|
0,56
|
0,61
|
0,70
| | Announcement Date | 04/18/2018 | 07/18/2018 | 10/17/2018 | 01/23/2019 | 04/17/2019 | 07/17/2019 | 10/16/2019 | 01/22/2020 | 04/16/2020 | 07/16/2020 | | | | | |
|
Financial data source
© 2020 S&P Global Market Intelligence
|
|
© 2020 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
Previous period
